Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

acute myeloid leukemia with myelodysplasia-related changes

(uh-KYOOT MY-eh-loyd loo-KEE-mee-uh … MY-eh-loh-dis-PLAY-zhuh-ree-LAY-ted CHAYN-jiz)
A type of acute myeloid leukemia in which at least 20% of a patient’s blood or bone marrow is myeloblasts (immature white blood cells) and the patient has one of the following conditions: 1) has had myelodysplastic syndrome (MDS) or a myelodysplastic/myeloproliferative neoplasm (MDS/MPN) before, 2) cells that have changes in certain chromosomes that are similar to those found in MDS, or 3) at least 50% of the cells (of at least two types of blood cells) are abnormal. Acute myeloid leukemia with myelodysplasia-related changes usually occurs in older adults and has a poor prognosis. Also called AML-MRC.
Search NCI's Dictionary of Cancer Terms